Navigation Links
China Nepstar Chain Drugstore Reports Second Quarter 2011 Financial Results
Date:8/23/2011

SHENZHEN, China, Aug. 23, 2011 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2011.

Financial HighlightsFor the quarter ended June 30, 2011:

  • Revenue increased by 7.3% to RMB606.6 million (US$93.8 million), compared to revenue of RMB565.2 million in the second quarter of 2010.
  • Same store sales increased by 9.8% over the same period in 2010.
  • Gross margin was 47.8%.
  • Net income was RMB6.5 million (US$1.0 million).
  • Net cash flow from operations was RMB42.6 million (US$6.6 million).

  • Mr. Simin Zhang, Chairman of the Board of Nepstar, commented, "Our merchandise diversification efforts continue to help mitigate the negative impact of price cuts imposed by government on pharmaceutical products. During the quarter, we achieved a 9.8% increase in same store sales compared to that in the second quarter of 2010. While we are expanding our revenues, we remain focused on optimizing our product mix, both in pharmaceutical categories and in non-pharmaceutical categories, to protect gross margins."

    "Driving revenue growth and remaining competitive with an optimal product mix remain the central themes of our strategy at this stage," continued Mr. Zhang. "We are encouraged that our existing customers are attracted to the new product categories we have introduced so far and we are utilizing this opportunity to highlight service quality and the overall shopping experience in an effort to improve average spending per customer visit and same store productivity."

    Second Quarter ResultsDuring the second quarter of 2011, the Company opened 18 new stores and closed 40 stores. As of June 30, 201
    '/>"/>

    SOURCE China Nepstar Chain Drugstore Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
    2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
    3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
    4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
    5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
    6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
    7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
    8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
    9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
    10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
    11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/17/2014)...  Neuraltus Pharmaceuticals, Inc. announced today that promising efficacy ... NP001 for the treatment of amyotrophic lateral sclerosis (ALS, ... today in an oral presentation at the inaugural ... in Bloomington, Minnesota , September 17-19, ... a high dose of NP001 (2mg/kg) was associated with ...
    (Date:9/17/2014)... , Sept. 17 2014 IBM (NYSE: ... is using IBM technical computing and storage technology ... cancer patients. These services deliver critically important information ... each patient,s unique cancer, which could lead to ... healthcare system in general. Today, optimal ...
    (Date:9/17/2014)... Switzerland , September 17, 2014 /PRNewswire/ ... , is proud to congratulate Biocartis commitment in ... Diagnostics is a long-time investor in Biocartis as ... ™ Biocartis, fully automated, real-time PCR based ... fast and easy access to clinical molecular diagnostic ...
    Breaking Medicine Technology:Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 3Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 2Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 3Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 4Debiopharm Diagnostics Portfolio Company Biocartis Ships its First Idylla Instrument 2
    ... N.J. , March 11 Bayer HealthCare ... been granted by the U.S. Food and Drug Administration ... of pulmonary infection due to Pseudomonas aeruginosa in cystic ... granted by the European Medicines Agency. Ciprofloxacin DPI is ...
    ... DETROIT , March 11 Caraco Pharmaceutical ... oxaliplatin injections. These 50mg and 100mg oxaliplatin injections, which ... from the US Food and Drug Administration (FDA) for ... an anticancer used in the treatment of colon and ...
    Cached Medicine Technology:FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 2FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 3FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 4FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 5FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 6FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 7FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 8Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 3
    (Date:9/17/2014)... Experienced dress company, Discount-Dress.com, announces that ... of trendy black bridesmaid dresses. Furthermore, the company has ... bridesmaid outfits. Readers can view more about ... is a famous brand of special occasion gowns ... well as revamped old editions, the supplier has set ...
    (Date:9/17/2014)... 2014 Headquartered in Baltimore, Maryland, ... across the country. , “The past two weeks ... have grown to over 400 evaluators in 46 states, ... in the Midwest and South Dakota and Vermont. And ... where our volunteers can visit.” , TPU provides one-of-a-kind ...
    (Date:9/17/2014)... (PRWEB) September 17, 2014 Request A ... lab testing, is offering 10% off drug testing ... to all drug tests, including those ordered by employers for ... take advantage of this discount by using promo code DRUG10 ... increase in positives on workplace drug testing, especially for marijuana ...
    (Date:9/17/2014)... New York (PRWEB) September 17, 2014 ... together with experienced coaches to complete a three stage ... Adventure Team Challenge New York . , Hosted ... York’s Catskill Mountains, the 2014 Challenge includes five participating ... coaches for each athlete with disabilities will provide expert ...
    (Date:9/17/2014)... 17, 2014 ICS Learning Group, Inc. ... Excellence in Training for the Best Use of Games ... on an online operational safety training module that ICS ... operation. Using an approach that combined realistic 3D ... that was similar to a video game, including competition ...
    Breaking Medicine News(10 mins):Health News:Discount-Dress.com’s Top Designers Are Now Busy Making Its New Black Bridesmaid Dresses 2Health News:Therapy Pets Unlimited is Expanding 2Health News:Therapy Pets Unlimited is Expanding 3Health News:Request A Test Can Save You 10% on Drug Testing 2Health News:Request A Test Can Save You 10% on Drug Testing 3Health News:World T.E.A.M. Sports’ Adventure Team Challenge New York Includes Disabled Athletes 2Health News:World T.E.A.M. Sports’ Adventure Team Challenge New York Includes Disabled Athletes 3Health News:ICS Learning Group Wins Gold in the 2014 Brandon Hall Excellence Competition for Best Use of Games and Simulations for Learning 2
    ... As the connection between second-hand smoke and coronary heart ... reduce such passive smoking, exposures have been reduced. In ... the American Journal of Preventive Medicine , researchers ... Boston and Columbia University have recalibrated the CHD Policy ...
    ... Prior Year Quarter --, ... ... , TSX Venture Exchange: NVC , , ... specialty vascular device company, today announced financial results for the third quarter and ...
    ... - The Westaim Corporation today announced it has requisitioned ... to consider a return of capital to NUCRYST shareholders ... will continue to review alternatives to maximize the value ... the Alberta Business Corporations Act, NUCRYST,s Board of Directors ...
    ... nicotine use, personality illnesses common, study shows , , ... common among young adults in the United States, but ... reach this finding, U.S. researchers analyzed data from more ... part in the National Epidemiologic Survey on Alcohol and ...
    ... The Arthritis Foundation announces the 2008 winners of the ... The recipients, Dr. Gerard Karsenty of the Columbia University ... University received the award for their continued research advancements ... , Dr. Karsenty is recognized for his research in ...
    ... 1 Senetek PLC,(OTC Bulletin Board: SNKTY), a life ... the science of healthy aging,announced today that Dynamics Group ... and research with offices in Zurich,Bern and Geneva has ... The Research Report, available ...
    Cached Medicine News:Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 2Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 3Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 4Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 5Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 6Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 7Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 8Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 9Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 10Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 11Health News:The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders 2Health News:Few Young Adults Seek Treatment for Psych Disorders 2
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: